Umedica Laboratories Private Limited Ranitidine Export Data — India (DGFT 2022–2026)

Name: Umedica Laboratories Private Limited Ranitidine Export Records India — #10 Exporter, 23 Shipments, $282.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ranitidine

India Pharmaceutical Trade Intelligence

$12.6M248 Suppliers104 CountriesHS 30049033

ExportsIndia → UZBEKISTAN20.7%India → CANADA19.3%

ImportsSINGAPORE → India$534

#1 Supplier: COMBITIC GLOBAL #1 Buyer: OOO SMARTPHARMO

Umedica Laboratories Private Limited — Ranitidine Exporter #10 | $282.0K Trade Value | TransData Nexus | TransData Nexus

Umedica Laboratories Private Limited — Ranitidine Exporter Profile

Indian Pharmaceutical Exporter · #10 for Ranitidine · $282.0K export value · DGFT Verified

Umedica Laboratories Private Limited is the #10 Indian exporter of Ranitidine with $282.0K in export value and 23 verified shipments. Umedica Laboratories Private Limited holds a 2.2% market share in Ranitidine exports across 5 countries. The company exports 11 pharmaceutical products worth $32.2M across 8 therapeutic categories.

Umedica Laboratories Private Limited — Ranitidine Export Profile: Buyers & Destinations

Umedica Laboratories Private Limited Ranitidine export treemap — buyers and destination countries | TransData Nexus

Where Does Umedica Laboratories Private Limited Export Ranitidine?

Country	Value	Shipments	Share
MYANMAR	$134.1K	12	47.5%
GAUTEMALA	$113.5K	4	40.3%
PHILIPPINES	$27.9K	5	9.9%
NEPAL	$3.8K	1	1.3%
MOZAMBIQUE

Who Are the Top Buyers of Ranitidine from Umedica Laboratories Private Limited?

Buyer	Country	Value	Orders
PHARMACEUTICAL PRODUCTS LTD	MYANMAR	$134.1K	12
CORPORACION UMED, S,A,	GAUTEMALA	$113.5K	4
SUHITAS PHARMACEUTICALS INC	PHILIPPINES	$15.5K	3
SUHITAS PHARMACEUTICALS INC.,	PHILIPPINES	$12.4K	2
PHARMACARE INTERNATIONAL	NEPAL	$3.8K	1
AFRI FARMACIA LDA	MOZAMBIQUE	$2.7K	1

Umedica Laboratories Private Limited supplies Ranitidine to 6 buyers globally. The largest buyer is PHARMACEUTICAL PRODUCTS LTD (MYANMAR), followed by CORPORACION UMED, S,A, (GAUTEMALA) and SUHITAS PHARMACEUTICALS INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ranitidine Formulations Does Umedica Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
RANITIDINE TABLETS USP 300MG (BOX OF 10X	$113.5K	4
UMETAC (RANITIDINE INJECTION USP 50MG/2M	$62.0K	4
UMETAC (RANITIDINE INJECTION USP50MG/2ML) (BOX OF 1X10 AMPOULES)	$29.7K	2
UMETAC (RANITIDINE INJ USP50MG/2ML) (BOX OF 1X10 AMPOULES)	$29.7K	2
UMETAC (RANITIDINE INJECTION USP 50MG/2	$12.8K	4
AETIN (RANITIDINE INJECTION USP 50MG/2ML) (BOX OF 10 AMPOULES)	$6.2K	1
MD-CID (RANITIDINE INJECTION USP 50MG/2ML) (BOX OF 10 AMPOULES)	$6.2K	1
AETIN Ranitidine injection USP 50mg 2ml Pack Size 10X2ML	$6.1K	1
AETIN (RANITIDINE INJECTION USP 50MG/2M	$4.8K	1
CONTRACID RANITIDINE INJECTION USP 50MG 2ML BOX OF 10 AMPOULES	$4.6K	1

Umedica Laboratories Private Limited exports 12 distinct Ranitidine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RANITIDINE TABLETS USP 300MG (BOX OF 10X with 4 shipments worth $113.5K.

How Does Umedica Laboratories Private Limited Compare to Nearest Ranitidine Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	BRAWN LABORATORIES LIMITED	$313.1K	28	4	$11.2K
7	ARAVIS PHARMACEUTICALS	$300.0K	6	1	$50.0K
10	UMEDICA LABORATORIES PRIVATE LIMITED ★	$282.0K	23	5	$12.3K
11	VKT PHARMA PRIVATE LIMITED	$216.8K	6	1	$36.1K
12	AMN LIFE PRIVATE LIMITED	$195.9K	7	1	$28.0K

Umedica Laboratories Private Limited ranks #10 among 248 Indian Ranitidine exporters. Average shipment value of $12.3K compared to the market average of $34.8K. The closest competitors by value are BRAWN LABORATORIES LIMITED and ARAVIS PHARMACEUTICALS.

Which Indian Ports Ship Ranitidine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	345	17.3%
SAHAR AIR	244	12.2%
DELHI AIR CARGO ACC (INDEL4)	231	11.6%
NHAVA SHEVA SEA (INNSA1)	155	7.8%
DELHI AIR	144	7.2%
Bombay Air	79	4.0%
JNPT	70	3.5%
JNPT/ NHAVA SHEVA SEA	63	3.2%

Geopolitical & Trade Policy Impact on Umedica Laboratories Private Limited's Ranitidine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Umedica Laboratories. The Israel-Iran conflict has led to disruptions in Middle East trade routes, particularly affecting the Red Sea shipping lanes. Major shipping lines have imposed 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effectively increasing the cost of exporting goods through these routes. This escalation in shipping costs can erode profit margins and necessitate strategic adjustments in logistics and pricing strategies. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian goods by the US, including a 25% tariff announced in 2025, poses a significant challenge. This tariff could lead to increased costs for Indian pharmaceutical products in the US market, potentially affecting demand and profitability. (en.wikipedia.org)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a promising avenue for Umedica. The FTA eliminates tariffs on Indian pharmaceutical exports to the EU, providing a competitive advantage and facilitating market expansion. This agreement is expected to open a market worth $572.3 billion for Indian pharmaceutical and MedTech exports to Europe from 2027 onward. (mordorintelligence.com)

Umedica Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent Good Manufacturing Practice (GMP) requirements. Historically, non-compliance has led to import bans and reputational damage for Indian firms. For instance, in 2013, the FDA banned imports from certain Indian pharmaceutical companies due to GMP violations, highlighting the critical importance of adherence to quality standards. (comcec.org)

While specific regulatory events concerning Umedica Laboratories are not detailed in the available data, the company's sustained export performance suggests a commitment to maintaining high-quality standards and compliance with international regulations. Continuous investment in quality control systems and regulatory compliance is essential to navigate the evolving landscape and to capitalize on global market opportunities.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ranitidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Umedica Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 23 individual customs records matching Umedica Laboratories Private Limited exporting Ranitidine, covering 12 formulations to 5 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 533+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ranitidine

Ranitidine

Umedica Laboratories Private Limited — Ranitidine Exporter Profile

Umedica Laboratories Private Limited — Ranitidine Export Profile: Buyers & Destinations

Where Does Umedica Laboratories Private Limited Export Ranitidine?

Who Are the Top Buyers of Ranitidine from Umedica Laboratories Private Limited?

What Is India's Total Ranitidine Export Value and How Much Does Umedica Laboratories Private Limited Contribute?

What Is the Average Shipment Value for Umedica Laboratories Private Limited's Ranitidine Exports?

How Does Umedica Laboratories Private Limited Compare to Other Indian Ranitidine Exporters?

What Ranitidine Formulations Does Umedica Laboratories Private Limited Export?

How Does Umedica Laboratories Private Limited Compare to Nearest Ranitidine Exporters?

Which Indian Ports Ship Ranitidine Exports?

Geopolitical & Trade Policy Impact on Umedica Laboratories Private Limited's Ranitidine Exports

Umedica Laboratories Private Limited — Regulatory Compliance & Quality Standards

About Umedica Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ranitidine Export Data from Umedica Laboratories Private Limited

Ranitidine Stats

Company Overview

Top Products by Umedica Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source